
### [NCIT:C80280](http://purl.obolibrary.org/obo/NCIT_C80280)
**Label:** Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C45231](http://purl.obolibrary.org/obo/NCIT_C45231) (Diffuse Large B-Cell Lymphoma Unclassifiable), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8124](http://purl.obolibrary.org/obo/NCIT_C8124) (Stage II Adult Immunoblastic Lymphoma), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7873](http://purl.obolibrary.org/obo/NCIT_C7873) (Adult Immunoblastic Lymphoma), [NCIT:C7263](http://purl.obolibrary.org/obo/NCIT_C7263) (Thyroid Gland Immunoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074) (Centroblastic Lymphoma), [NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type), [NCIT:C3461](http://purl.obolibrary.org/obo/NCIT_C3461) (Immunoblastic Lymphoma), [NCIT:C36080](http://purl.obolibrary.org/obo/NCIT_C36080) (Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C45219](http://purl.obolibrary.org/obo/NCIT_C45219) (Diffuse Large B-Cell Lymphoma by Gene Expression Profile), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C6916](http://purl.obolibrary.org/obo/NCIT_C6916) (Anaplastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36642](http://purl.obolibrary.org/obo/NCIT_C36642) (Cyclin D1 Messenger RNA Overexpression))) 56.77%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36640](http://purl.obolibrary.org/obo/NCIT_C36640) (c-erbB2 Messenger RNA Overexpression))) 56.77%
- Thing 55.08%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37012](http://purl.obolibrary.org/obo/NCIT_C37012) (Neoplastic T-Immunoblast))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37006](http://purl.obolibrary.org/obo/NCIT_C37006) (Neoplastic Medium-Sized B-Lymphocyte with Eccentric Basophilic Cytoplasm))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37003](http://purl.obolibrary.org/obo/NCIT_C37003) (Neoplastic Monocytoid B-Lymphocyte))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37002](http://purl.obolibrary.org/obo/NCIT_C37002) (Neoplastic Small Cleaved Follicle Center Cell))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37001](http://purl.obolibrary.org/obo/NCIT_C37001) (Centrocyte-Like Cell))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C37000](http://purl.obolibrary.org/obo/NCIT_C37000) (Lymphoplasmacytoid Cell))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36991](http://purl.obolibrary.org/obo/NCIT_C36991) (Neoplastic Small to Medium-Sized B-Lymphocyte with Pale Cytoplasm))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36985](http://purl.obolibrary.org/obo/NCIT_C36985) (Neoplastic Chondroblast))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36981](http://purl.obolibrary.org/obo/NCIT_C36981) (Ganglion-Like Cell))) 54.84%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36975](http://purl.obolibrary.org/obo/NCIT_C36975) (Signet Ring Lipoblast))) 54.84%


